β-Lactamase-IN-8

• UNSPSC Description:

  β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor. β-Lactamase-IN-8 can be used for researching antibacteria[1].

• Target Antigen:

  Bacterial; Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/β-lactamase-in-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N[C@@H](CC=C[C@]1([H])C2)B(O1)OC2=O)CSC

• Molecular Weight:

  255.10

• References & Citations:

  [1]Raja Reddy K, et al. Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability. Bioorg Med Chem. 2022;62:116722.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1929555-36-1